Conclusion: The sirolimus-eluting coronary stent is associated with less ISR than non-drug-containing stents, but further investigation is needed to determine its exact place in the treatment of ...

Novel drug-coated balloons (DCB) did not outshine standard treatment with second generation drug-eluting stents (DES ...

A study has found that sirolimus-coated balloons vs thin drug-eluting stents in in-stent restenosis show similar favorable clinical outcomes.

Drug-coated balloon (DCB) angioplasty as the initial strategy for de novo coronary artery stenoses didn't measure up to ...

Among patients undergoing non-cardiac surgery more than one year after coronary drug-eluting stent (DES) implantation, there was no difference with respect to ischemic outcomes or major bleeding ...

A non-exhaustive summary of reported cases ... There are two main types of stents: bare metal stents and drug-eluting stents. Bare metal stents are composed of different alloys (typically with ...

The financing will contribute to gain FDA approval for new technologies like Orthobond previously did with Ostaguard, its anti-bacterial non-drug eluting solution for spine implants, it stated.

Undergoing percutaneous coronary intervention (PCI) for narrowed arteries with a novel bioadaptor is at least as effective as ...

Translumina was incorporated in 2011 as a sales & marketing company specialising in coronary intervention devices. Since its inception, the company has successfully established their own manufacturing ...

Using optimal coherence tomography (OCT) to guide stent implantation during percutaneous coronary intervention (PCI) in ...